Mark Nespeca
Affiliations: | Neurosciences | University of California, San Diego, La Jolla, CA |
Google:
"Mark Nespeca"Mean distance: 106866
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Cassater D, Bustamante M, Sach-Peltason L, et al. (2021) Clinical Characterization of Epilepsy in Children With Angelman Syndrome. Pediatric Neurology. 124: 42-50 |
Macdonald-Laurs E, Sharpe C, Nespeca M, et al. (2020) Does the first hour of continuous electroencephalography predict neonatal seizures? Archives of Disease in Childhood. Fetal and Neonatal Edition |
Sharpe C, Reiner GE, Davis SL, et al. (2020) Levetiracetam Versus Phenobarbital for Neonatal Seizures: A Randomized Controlled Trial. Pediatrics |
Sharpe C, Davis SL, Reiner GE, et al. (2018) Assessing the Feasibility of Providing a Real-Time Response to Seizures Detected With Continuous Long-Term Neonatal Electroencephalography Monitoring. Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society |
Kanner AM, Ashman E, Gloss D, et al. (2018) Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Epilepsy Currents. 18: 269-278 |
Kanner AM, Ashman E, Gloss D, et al. (2018) Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Epilepsy Currents. 18: 260-268 |
Kanner AM, Ashman E, Gloss D, et al. (2018) Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology |
Kanner AM, Ashman E, Gloss D, et al. (2018) Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology |
Johannesen KM, Gardella E, Linnankivi T, et al. (2018) Defining the phenotypic spectrum of SLC6A1 mutations. Epilepsia |
Rismanchi N, Gold JJ, Sattar S, et al. (2015) Epilepsy After Resolution of Presumed Childhood Encephalitis. Pediatric Neurology. 53: 65-72 |